Skip to main content

Table 2 Immunohistochemistry analysis in gastric tumors

From: Deregulated expression of Nucleophosmin 1 in gastric cancer and its clinicopathological implications

Case

Histological subtype

Differentiation

Stage

% of stained tumor cells

Location

Intensity of staining

Score

1

Intestinal-type

Moderately differentiated

1

60%

Nucleus

Moderate

2

Nucleolus

Moderate

2

2

Intestinal-type

Poorly differentiated

4

< 10%

Nucleus

Weak

0

Nucleolus

Moderate

0

3

Intestinal-type

Moderately differentiated

4

40%

Nucleus

Weak

1

Nucleolus

Moderate

2

4

Intestinal-type

Moderately differentiated

1

20%

Nucleus

Moderate

2

Nucleolus

Moderate

2

5*

Intestinal-type

Moderately differentiated

1

40%

Nucleus

Weak

1

Nucleolus

Moderate

2

6

Intestinal-type

Poorly differentiated

3

< 10%

Nucleus

Weak

0

Nucleolus

Weak

0

7

Intestinal-type

Moderately differentiated

1

< 10%

Nucleus

Weak

0

Nucleolus

Weak

0

8

Intestinal-type

Moderately differentiated

3

< 10%

Nucleus

Weak

0

Nucleolus

Weak

0

9

Intestinal-type

Moderately differentiated

4

20%

Nucleus

Weak

1

Nucleolus

Moderate

2

10

Intestinal-type

Moderately differentiated

2

< 10%

Nucleus

Weak

0

Nucleolus

Weak

0

11

Intestinal-type

Poorly differentiated

3

40%

Nucleus

Weak

1

Nucleolus

Moderate

2

12

Diffuse-type

Not applied

3

20%

Nucleus

Moderate

2

Nucleolus

Moderate

2

  1. *This patient presented strong cytoplasmatic immunoreactivity in normal parietal cells (score = 3).